Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Conference Program for 2021 the World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    MA02 - RET and Novel Combinations of Osimertinib

    • 09:30 - 10:30
    • 9/08/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Novel Therapeutics and Targeted Therapies
    • +

      MA02.06 - Phase 1b Study of Pelcitoclax (APG-1252) in Combination With Osimertinib in Patients With EGFR TKI-Resistant NSCLC

      10:05 - 10:10  |  Presenter: Li Zhang

      • Abstract

      Loading...

  • +

    MA03 - Biomarkers for Immunotherapy: Are All Relevant?

    • 10:45 - 11:45
    • 9/08/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • +

      MA03.05 - DNA Damage Response (DDR) Gene Mutations and Correlation With Immunotherapy Response in NSCLC Patients

      11:15 - 11:20  |  Presenter: Jiaqing Liu

      • Abstract

      Loading...

  • +

    P17 - Immunotherapy (Phase II/III Trials) - First-Line, Advanced, Squamous NSCLC

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • +

      P17.01 - KEYNOTE-407 China Extension Final Analysis: Pembrolizumab Plus Chemotherapy for the Treatment of Metastatic Squamous NSCLC

      00:00 - 00:00  |  Presenter: Ying Cheng

      • Abstract

      Loading...

  • +

    P22 - Liquid Biopsy and Other Non-invasive Diagnostic Modalities - Monitoring/Prognosis

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
    • +

      P22.06 - Prognostic Value of Circulating Tumor Cells in Patients With Small Cell Lung Cancer Receiving Front-Line Treatment

      00:00 - 00:00  |  Presenter: Haohua Zhu

      • Abstract

      Loading...

  • +

    P24 - Liquid Biopsy and Other Non-invasive Diagnostic Modalities - Targeted Therapy

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
    • +

      P24.02 - Unique Efficacy of Ensartinib on Different ALK Fusion Subtypes Evaluated by Plasma ctDNA

      00:00 - 00:00  |  Presenter: Tao Wang

      • Abstract

      Loading...

  • +

    P57 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - ICI Biomarkers

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
    • +

      P57.13 - Correlation of TP53/KMT2C co-mutation and Tumor Microenvironment in Lung Cancer

      00:00 - 00:00  |  Presenter: Xuhui Zhang

      • Abstract

      Loading...

  • +

    P64 - Small Cell Lung Cancer/ NET - Clinical Trial in Progress

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Small Cell Lung Cancer/ NET
    • +

      P64.04 - Hypo-Fractionated Versus Conventionally Fractionated Radiotherapy for Patients with LS-SCLC: An Open-Label, Randomized, Phase 3 Trial

      00:00 - 00:00  |  Presenter: Nan Bi

      • Abstract

      Loading...